Herd immunity is a key concept for epidemic control. It states that only a proportion of a population needs to be immune (through overcoming natural infection or through vaccination) to an infectious agent for it to stop generating large outbreaks. A key question in the current COVID-19 pandemic is how and when herd immunity can be achieved and at what cost.
We had a virtual workshop 4-7 pm (Central African Time) on Wednesday, Thursday & Friday 9-11th September 2020 with the theme “Building Teamwork for Primary Health Care in Africa”. It was open to anyone interested but was targeted towards country leaders of participating organisations of AfroPHC.
Scientists in the People’s Liberation Army helped to develop the world’s first COVID-19 vaccine to be approved for restricted use.
The Access to COVID-19 Tools (ACT) Accelerator, is a groundbreaking global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
The COVID-19 pandemic has created unprecedented disruption for the global health and development community. Organizations fighting infectious disease, supporting health workers, delivering social services, and protecting livelihoods have moved to the very center of the world’s attention. But they find their work complicated by challenges of access, safety, supply chain logistics, and financial stress like never before.